Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Camac Fund, LP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2023 4 Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp
Txns: Sold 70,000 shares @ $0.1553, valued at $10.9k
08/25/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
08/25/2023 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
08/23/2023 SC 13D Camac Fund, LP reports a 4.3% stake in Forte Biosciences, Inc.
08/17/2023 PRRN14A Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
08/03/2023 SC 13D/A Camac Fund, LP reports a 3.6% stake in Forte Biosciences Inc.
07/27/2023 SC 13D/A Camac Fund, LP reports a 13.9% stake in Gold Reserve Inc.
07/05/2023 SC 13D/A Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc.
06/29/2023 4 Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp
Txns: Sold 202,500 shares @ $0.15, valued at $30.4k
06/09/2023 4 Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp
Txns: Sold 15,000 shares @ $0.15, valued at $2.3k
05/31/2023 SC 13D/A Camac Fund, LP reports a 19.7% stake in Ambase Corp.
05/26/2023 4 Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp
Txns: Sold 12,000 shares @ $0.1, valued at $1.2k
Sold 1,000,000 shares @ $0.1, valued at $100k
05/25/2023 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
05/25/2023 SC 13D/A Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc.
05/10/2023 4 Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp
Txns: Sold 10,000 shares @ $0.11, valued at $1.1k
Sold 20,000 shares @ $0.095, valued at $1.9k
03/02/2023 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
03/02/2023 SC 13G/A Camac Fund, LP reports a 13.5% stake in Impac Mortgage Holdings, Inc.
02/21/2023 SC 13D/A Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc.
01/30/2023 4 Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp
Txns: Sold 50,000 shares @ $0.1, valued at $5k
01/10/2023 SC 13D/A Camac Fund, LP reports a 0% stake in Pasithea Therapeutics Corp.
12/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2022 SC 13D/A Camac Fund, LP reports a 6.1% stake in Pasithea Therapeutics Corp.
12/07/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
11/22/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
11/17/2022 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
11/08/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/03/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/01/2022 SC 13D/A Camac Fund, LP reports a 6.7% stake in Pasithea Therapeutics Corp.
10/25/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/13/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
10/12/2022 PRRN14A Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
09/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy